🇺🇸 FDA
Patent

US 6964953

Methods for treating stress disorders using glucocorticoid receptor-specific antagonists

expired A61KA61K31/56A61K31/57

Quick answer

US patent 6964953 (Methods for treating stress disorders using glucocorticoid receptor-specific antagonists) held by Corcept Therapeutics Incorporated expires Mon Nov 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Corcept Therapeutics Incorporated
Grant date
Tue Nov 15 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/56, A61K31/57, A61K31/59, A61P